Karishma Khullar, MD

---

---

Description of Research Expertise

Healthcare disparities

Description of Clinical Expertise

Radiotherapy for GI malignancies

Selected Publications

• Perlow HK, Khullar K, Kumar R, Sasmal S, Nakamoto K, Gokun Y, Eckstein J, Young R, Diaz DA, Martin D, et al : Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer. Current Oncology 32(6) : 353, June 2025
• Khullar K, Deek RA, Nelson B, Gaines D, Corrigan KL, LeCompte MC, Deville C Jr, Deek MP, Jabbour SK. : Gender and the Receipt of the Association of Residents in Radiation Oncology Educator of the Year Award Adv Radiat Oncol 9(1) : 101305, Oct 2023
• Khullar K, Plascak JJ, Parikh RR : Acute lymphoblastic leukemia (ALL) in adults: disparities in treatment intervention based on access to treatment facility Leukemia & Lymphoma 63(1) : 170-178, Sep 2021
• Khullar K, Hanft S, Mehnert JM, Weiner JP : Complete response of brainstem metastasis in BRAF-mutated melanoma without stereotactic radiosurgery after initiation of encorafenib and binimetinib Melanoma Res 31(4) : 393-396, Aug 2021
• Modi C, Dragun AE, Henson CF, Jain S, Ahlawat S, Eastwick G, Kubicek GJ, Mezera M, Mulvihill DJ, Perri J, Juneja B, Khullar K, Ennis RD, Haffty BG : A Statewide Multi-Institutional Study of Asymptomatic Pretreatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United States Adv Radiat Oncol 6(4) : 100704, Jul-Aug 2021
• Khullar K, Dhawan ST, Nosher J, Jabbour SK : Fiducial marker migration following computed tomography-guided placement in the liver: a case report AME Case Reports 5 : 15, Apr 2021
• Khullar K & Parikh RR : The role of radiotherapy in metastatic prostate cancer Am J Clin Exp Urol 7(2) : 92-97, Apr 2021
• Khullar K, Plasack JJ, Drachtman R, Cole PD, Parikh RR : Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma Cancer Medicine 10(4) : 1327-1334, Feb 2021
• Wang SJ, Khullar K, Kim S, Crayton SH, Yegya-Raman N, Groisberg R, Silk AW, Nosher JL, Malhotra J, Gentile MA, Mehnert JM, Jabbour SK. : Cyclooxygenase inhibitor use during checkpoint immunotherapy and effect on time to progression and overall survival for metastatic melanoma and non-small cell lung cancer patients. Journal for ImmunoTherapy of Cancer Oct 2020
• Wang SJ, Khullar K, Kim S, Yegya-Raman N, Malhotra J, Groisberg R, Crayton SH, Silk AW, Nosher JL, Gentile MA, Mehnert JM, Jabbour SK : Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer J Immunother Cancer 8(2) : e000889, Oct 2020